Raising the Bar for Myelofibrosis Therapy Constructing

Raising the Bar for Myelofibrosis Therapy Constructing

Rational mixture therapies, new-generation medications, and new therapeutic targets will push treatment for myelofibrosis beyond the novel focal level on the Janus kinase (JAK) inhibition, a specialist talked about for the period of the Society of Hematologic Oncology digital meeting.…